Finance

Beta
Lists
AUTL:NASDAQ
Autolus Therapeutics PLC
၁.၄၄ US$
-၁.၃၇%
(-၀.၀၂၀) 1D
၁.၄၇ US$
+၁.၈၂% (+၀.၀၂၆)
Pre-market
Closed: ဇူ ၁၇, GMT-၄ ၁၆:၀၀:၀၀  ·   USD
All symbols
SymbolPriceChange% Change
Generating top insights for AUTL...
Open
၁.၄၅ US$
High
၁.၄၇ US$
Low
၁.၄၂ US$
Mkt. cap
၃၈.၃၃ ကုဋေ
Avg. vol.
၁.၂၄ သန်း
Volume
၀.၀၀
52-wk high
၂.၇၀ US$
52-wk low
၁.၁၈ US$
EPS
-၁.၀၉ US$
Beta
၂.၀၄
Shares outstanding
၂၆.၆၂ ကုဋေ
No. of employees
၇၅၃
Open
၁.၄၅ US$
High
၁.၄၇ US$
Low
၁.၄၂ US$
Mkt. cap
၃၈.၃၃ ကုဋေ
Avg. vol.
၁.၂၄ သန်း
Volume
၀.၀၀
52-wk high
၂.၇၀ US$
52-wk low
၁.၁၈ US$
EPS
-၁.၀၉ US$
Beta
၂.၀၄
Shares outstanding
၂၆.၆၂ ကုဋေ
No. of employees
၇၅၃
News stories
From sources across the web
https://www.dars.gov.et/
https://www.dars.gov.et/
·
ပြီးခဲ့သည့် ၂ ရက်
AUTL Q1 2026 Earnings: EPS Miss Reflects Continued R&D Investment, Stock Declines - Earnings Analysis
About Autolus Therapeutics PLC
CEOChristian Itin
Employees၇၅၃
Founded၂၀၁၄
Headquarters-
Sector-
Analyst ratings
Based on 6 analysts giving stock ratings to AUTL in the past 3 months
Strong buy
Buy
6
Hold
0
Sell
0
12-month forecast
Based on 6 Wall Street analysts offering 12 month price targets for AUTL in the last 3 months.
Highest
Current ၁.၄၄ US$
၁၀.၀၀ US$ (+၅၉၄.၄၄%)
Average
၈.၀၈ US$ (+၄၆၁.၁၁%)
Lowest
၅.၀၀ US$ (+၂၄၇.၂၂%)
Analyst
Recommendation
Action
Price target
Projected
Date
Emily Bodnar
H.C. Wainwright
Buy
Maintained
၁၀.၀၀ US$
+၅၉၄.၄%
07/13/2026
Salim Syed
Mizuho Securities
Buy
Maintained
၁၀.၀၀ US$
+၅၉၄.၄%
06/10/2026
Matt Phipps
William Blair
Buy
Maintained
-
-
06/02/2026
Unknown Analyst
Wells Fargo
Buy
Reiterated
၅.၀၀ US$
+၂၄၇.၂%
05/15/2026
Unknown Analyst
Goldman Sachs
Buy
Reiterated
၅.၄၀ US$
+၂၇၅%
05/15/2026
Gil Blum
Needham
Buy
Maintained
၁၀.၀၀ US$
+၅၉၄.၄%
05/14/2026
Last report
၂၀၂၆ မေ ၁၄
Fiscal period
Q1 2026
EPS / Est. (USD)
-၀.၂၇ US$ / -၀.၂၆ US$
-၄.၂၀%miss
Revenue / Est. (USD)
၂.၆၂ ကုဋေ / ၂.၆၁ ကုဋေ
+၀.၃၃%beat
Fiscal Q1 2026 earnings call
Waiting for the earnings call
At a glance
Insights from the latest news and reports
Previous reportsAll values in USD
Loading Previous Earnings...
Income statement
Revenue
Net income
All values in USD
၂၀၂၅ ဇွန်
၂၀၂၅ စက်
၂၀၂၅ ဒီ
၂၀၂၆ မတ်
Revenue
၂.၀၉ ကုဋေ
၂.၁၂ ကုဋေ
၂.၄၃ ကုဋေ
၂.၆၂ ကုဋေ
Cost of goods sold
၂.၆၀ ကုဋေ
၅.၆၅ ကုဋေ
၅.၄၃ ကုဋေ
၄.၅၈ ကုဋေ
Cost of revenue
၂.၆၀ ကုဋေ
၅.၆၅ ကုဋေ
၅.၄၃ ကုဋေ
၄.၅၈ ကုဋေ
Research and development expenses
၂.၅၉ ကုဋေ
-
-
-
Total research and development expenses
-
-
-
-
Selling, general, and admin expenses
၃.၀၃ ကုဋေ
၃.၆၃ ကုဋေ
၄.၂၁ ကုဋေ
၄.၀၀ ကုဋေ
Operating expense
၅.၆၂ ကုဋေ
၃.၆၃ ကုဋေ
၄.၂၁ ကုဋေ
၄.၀၀ ကုဋေ
Total operating expenses
၈.၂၁ ကုဋေ
၉.၂၈ ကုဋေ
၉.၆၄ ကုဋေ
၈.၅၇ ကုဋေ
Operating income
-၆.၁၂ ကုဋေ
-၇.၁၆ ကုဋေ
-၇.၂၁ ကုဋေ
-၅.၉၅ ကုဋေ
Other non operating income
၁.၇၇ ကုဋေ
၈.၄၀ သောင်း
-၁.၁၇ ကုဋေ
၁.၀၀ သိန်း
EBT including unusual items
-၄.၇၅ ကုဋေ
-၇.၈၆ ကုဋေ
-၉.၁၅ ကုဋေ
-၇.၀၇ ကုဋေ
EBT excluding unusual items
-၄.၇၅ ကုဋေ
-၇.၈၆ ကုဋေ
-၉.၁၂ ကုဋေ
-၇.၀၇ ကုဋေ
Income tax expense
၃.၉၇ သိန်း
၅.၃၂ သိန်း
-၁.၁၈ သန်း
၈.၆၃ သိန်း
Effective tax rate
-၀.၈၄%
-၀.၆၈%
၁.၂၉%
-၁.၂၂%
Other operating expenses
-
-
-
-
Net income
-၄.၇၉ ကုဋေ
-၇.၉၁ ကုဋေ
-၉.၀၃ ကုဋေ
-၇.၁၆ ကုဋေ
Net profit margin
-၂၂၉.၀၂%
-၃၇၃.၃၀%
-၃၇၁.၉၀%
-၂၇၃.၀၉%
Earnings per share
-၀.၁၈
-၀.၃၀
-၀.၃၄
-၀.၂၇
Interest and investment income
၅.၂၃ သန်း
၄.၃၈ သန်း
၃.၂၃ သန်း
၂.၄၇ သန်း
Interest expense
-၁.၀၇ ကုဋေ
-၁.၀၅ ကုဋေ
-၁.၁၀ ကုဋေ
-၁.၁၁ ကုဋေ
Net interest expenses
-၅.၄၆ သန်း
-၆.၁၄ သန်း
-၇.၇၈ သန်း
-၈.၆၆ သန်း
Depreciation and amortization charges
-
-
-
-
EBITDA
-၅.၈၈ ကုဋေ
-၆.၉၁ ကုဋေ
-၆.၉၅ ကုဋေ
-၅.၆၈ ကုဋေ
Gain or loss from assets sale
-
-
၁.၁၀ သောင်း
၂.၀၀ ထောင်
Insider transactions
Insider transactions data is drawn from third-party sources. Learn more
Insider
Position
Type
Date
Shares
Amount
Page 1
AI content may include mistakes. Learn more

Research

What's on your mind?
What's going on with the markets today?
Explore what’s possible
Create a portfolio
Create a task
Deep Search
AI content may include mistakes. Learn more